Related Experiment Video
Updated: Feb 8, 2026

Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
Novel Diagnostic Approaches for Eosinophilic Lung Diseases
Alexander Ruzic1, Merritt L Fajt2, Mark Hammer3
1Division of Respirology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
New biomarkers are needed for eosinophilic lung diseases (ELDs) because current methods fail to predict treatment response. Emerging tools offer precise, tissue-specific insights for better diagnosis and personalized medicine.
Area of Science:
- Pulmonology and immunology
- Biomarker discovery and validation
- Precision medicine in respiratory diseases
Background:
- Eosinophilic lung diseases (ELDs) are diverse, unified by eosinophilic inflammation but with varied clinical courses and treatment responses.
- Current biomarkers (blood eosinophils, BAL, sputum cytology, FeNO) inadequately predict or monitor response to targeted biologics, especially IL-5/IL-5R inhibitors.
- Limitations in distinguishing IL-5-dependent vs. independent pathways and assessing compartment-specific inflammation necessitate improved diagnostic strategies.
Purpose of the Study:
- To highlight the limitations of traditional biomarkers in eosinophilic lung diseases (ELDs).
- To introduce emerging non-invasive and functional imaging biomarker platforms for refined endotyping.
- To emphasize the shift towards mechanistically informed, tissue-specific, multimodal biomarker strategies for precision medicine in ELDs.
Main Methods:
- Review of current diagnostic tools and their limitations in ELDs.
- Exploration of novel non-invasive biomarker platforms: eosinophil peroxidase assays, breathomics, cytokine profiling, and composite models.
- Integration of advanced functional imaging techniques: hyperpolarized gas MRI, phase-resolved functional lung MRI, and quantitative CT.
Main Results:
- Emerging biomarkers assess upstream drivers, activation states, tissue localization, and immune pathways beyond simple eosinophil counts.
- Functional imaging provides high-resolution, non-invasive visualization of regional lung ventilation, perfusion, and inflammation.
- These novel approaches offer complementary capabilities for diagnosis and monitoring.
Conclusions:
- There is a critical need for refined precision endotyping in ELDs due to the inadequacy of current biomarkers.
- Novel biomarker platforms and functional imaging represent a significant advancement in understanding and managing ELDs.
- These innovations facilitate mechanistically informed, tissue-specific, multimodal strategies, advancing precision medicine for ELDs.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Lung Capacity
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

